Sections
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 5 |
| 1.1 List of Tables | 5 | 1 |
| 1.2 List of Figures | 6 | 1 |
| 2 Introduction | 7 | 1 |
| 2.1 Coronary Guidewires Overview | 7 | 1 |
| 3 Products under Development | 8 | 4 |
| 3.1 Coronary Guidewires - Pipeline Products by Stage of Development | 8 | 1 |
| 3.2 Coronary Guidewires - Pipeline Products by Territory | 9 | 1 |
| 3.3 Coronary Guidewires - Pipeline Products by Regulatory Path | 10 | 1 |
| 3.4 Coronary Guidewires - Pipeline Products by Estimated Approval Date | 11 | 1 |
| 4 Coronary Guidewires - Pipeline Products under Development by Companies | 12 | 2 |
| 4.1 Coronary Guidewires Companies - Pipeline Products by Stage of Development | 12 | 1 |
| 4.2 Coronary Guidewires - Pipeline Products by Stage of Development | 13 | 1 |
| 5 Coronary Guidewires Companies and Product Overview | 14 | 23 |
| 5.1 Bioscan Technologies Inc. Company Overview | 14 | 1 |
| 5.1.1 Bioscan Technologies Inc. Pipeline Products &Ongoing Clinical Trials Overview | 14 | 1 |
| 5.2 Blueacre Technology Limited Company Overview | 15 | 1 |
| 5.2.1 Blueacre Technology Limited Pipeline Products &Ongoing Clinical Trials Overview | 15 | 1 |
| 5.3 Boston Scientific Corporation Company Overview | 16 | 1 |
| 5.3.1 Boston Scientific Corporation Pipeline Products &Ongoing Clinical Trials Overview | 16 | 2 |
| 5.4 CardioSert Ltd. Company Overview | 18 | 1 |
| 5.4.1 CardioSert Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 18 | 1 |
| 5.5 CVSL Inc. Company Overview | 19 | 1 |
| 5.5.1 CVSL Inc. Pipeline Products &Ongoing Clinical Trials Overview | 19 | 2 |
| 5.6 ENDOMATERIALS Company Overview | 21 | 1 |
| 5.6.1 ENDOMATERIALS Pipeline Products &Ongoing Clinical Trials Overview | 21 | 1 |
| 5.7 Georgia Institute of Technology Company Overview | 22 | 1 |
| 5.7.1 Georgia Institute of Technology Pipeline Products &Ongoing Clinical Trials Overview | 22 | 2 |
| 5.8 Guided Interventions LLC Company Overview | 24 | 1 |
| 5.8.1 Guided Interventions LLC Pipeline Products &Ongoing Clinical Trials Overview | 24 | 1 |
| 5.9 MaRVis Technologies GmbH Company Overview | 25 | 1 |
| 5.9.1 MaRVis Technologies GmbH Pipeline Products &Ongoing Clinical Trials Overview | 25 | 2 |
| 5.10 MicroPort Scientific Corporation Company Overview | 27 | 1 |
| 5.10.1 MicroPort Scientific Corporation Pipeline Products &Ongoing Clinical Trials Overview | 27 | 1 |
| 5.11 Occlutech International AB Company Overview | 28 | 1 |
| 5.11.1 Occlutech International AB Pipeline Products &Ongoing Clinical Trials Overview | 28 | 1 |
| 5.12 OVALUM Ltd. Company Overview | 29 | 1 |
| 5.12.1 OVALUM Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 29 | 1 |
| 5.13 St. Jude Medical, Inc. Company Overview | 30 | 1 |
| 5.13.1 St. Jude Medical, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 30 | 2 |
| 5.14 Terumo Corporation Company Overview | 32 | 1 |
| 5.14.1 Terumo Corporation Pipeline Products &Ongoing Clinical Trials Overview | 32 | 2 |
| 5.15 The Cleveland Clinic Foundation Company Overview | 34 | 1 |
| 5.15.1 The Cleveland Clinic Foundation Pipeline Products &Ongoing Clinical Trials Overview | 34 | 1 |
| 5.16 University of Illinois at Chicago Company Overview | 35 | 1 |
| 5.16.1 University of Illinois at Chicago Pipeline Products &Ongoing Clinical Trials Overview | 35 | 1 |
| 5.17 Vasostar Ltd. Company Overview | 36 | 1 |
| 5.17.1 Vasostar Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 36 | 1 |
| 6 Coronary Guidewires- Recent Developments | 37 | 42 |
| 6.1 Oct 12, 2016: Hydromer Announces Entering Into 2 Coating Service Agreements Leveraging Its Medical Device Subsidiary, Biosearch Medical Products | 37 | 1 |
| 6.2 Oct 10, 2016: St. Jude Medical Announces FDA Clearance and Launch of the New PressureWire X Guidewire Designed to Optimize PCI Procedures in Patients With Complex Anatomies | 37 | 1 |
| 6.3 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer | 38 | 1 |
| 6.4 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results | 39 | 1 |
| 6.5 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services | 40 | 1 |
| 6.6 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China | 40 | 1 |
| 6.7 Aug 30, 2016: MPSC Announces 2016 Interim Results | 41 | 1 |
| 6.8 Aug 25, 2016: Medtronic Reports First Quarter Financial Results | 42 | 3 |
| 6.9 Aug 01, 2016: AngioDynamics to Raise Funds through Public Offering of Shares | 45 | 1 |
| 6.10 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 | 45 | 1 |
| 6.11 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 | 46 | 1 |
| 6.12 Jul 26, 2016: Merit Medical Announces Appointment of New Director | 47 | 1 |
| 6.13 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer | 47 | 1 |
| 6.14 Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results | 48 | 2 |
| 6.15 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results | 50 | 2 |
| 6.16 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors | 52 | 1 |
| 6.17 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results | 52 | 1 |
| 6.18 Jul 05, 2016: Opsens Announces Fiscal 2016 Third Quarter Results Sales Of $2,125,000, Up 156% Year-Over-Year | 53 | 1 |
| 6.19 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic | 54 | 1 |
| 6.20 Jun 22, 2016: Opsens receives Health Canada approval for the sale of OptoWire II | 54 | 1 |
| 6.21 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation | 55 | 1 |
| 6.22 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day | 55 | 1 |
| 6.23 Jun 03, 2016: LEPUCARE established in India | 56 | 1 |
| 6.24 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results | 56 | 3 |
| 6.25 May 19, 2016: New Data Presented at EuroPCR 2016 Adds to the Growing Body of Clinical Evidence Supporting St. Jude Medical FFR Technology and LAA Closure | 59 | 1 |
| 6.26 May 18, 2016: St. Jude Medical Announces European Launch of the Latest in PressureWire Guidewire Technology to Measure Pressure Differences Across Narrowed Coronary Arteries | 60 | 1 |
| 6.27 May 17, 2016: Opsens Raises USD3.9 Million in Private Placement of Units | 61 | 1 |
| 6.28 Apr 28, 2016: Merit Medical Reports Sales Up 6.6% for the Quarter Ended March 31, 2016 | 61 | 1 |
| 6.29 Apr 27, 2016: Boston Scientific Announces Results For First Quarter 2016 | 62 | 1 |
| 6.30 Apr 20, 2016: Abbott Reports First-Quarter 2016 Results | 63 | 3 |
| 6.31 Apr 19, 2016: Opsens announces results for its second quarter 2016 | 66 | 1 |
| 6.32 Apr 07, 2016: AngioDynamics Reports Fiscal 2016 Third Quarter Results | 67 | 1 |
| 6.33 Mar 23, 2016: MicroPort Signs Cooperation Agreement with Beijing Weimai Medical Device | 68 | 1 |
| 6.34 Mar 16, 2016: Opsens Receives Fda 510(K) Clearance For The Optowire II | 68 | 1 |
| 6.35 Mar 08, 2016: MicroPort Angiography Guidewire Obtains CFDA Registration Certificate | 69 | 1 |
| 6.36 Feb 25, 2016: Boston Scientific Announces Changes to Board of Directors | 69 | 1 |
| 6.37 Feb 23, 2016: Lepu Medical Amends Private Placement of Shares for USD110 Million | 70 | 1 |
| 6.38 Feb 22, 2016: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2015 | 70 | 2 |
| 6.39 Feb 04, 2016: Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2015 | 72 | 1 |
| 6.40 Feb 02, 2016: Mostyn Law wins court order barring Boston Scientific from destroying evidence | 73 | 1 |
| 6.41 Dec 22, 2015: Opsens Raises Funds in Private Placement of Units | 73 | 1 |
| 6.42 Dec 03, 2015: Opsens Raises USD3.8 Million in Public Offering of Units | 73 | 1 |
| 6.43 Nov 27, 2015: FDA Identifies Boston Scientific s Recall Of RotaWire Elite Core Wires As Class I | 74 | 1 |
| 6.44 Nov 26, 2015: OPSENS granted approval to sell Optowire II in Japan | 74 | 1 |
| 6.45 Nov 12, 2015: OPSENS granted approval to sell OptoWire II in Europe | 75 | 1 |
| 6.46 Nov 11, 2015: Opsens announces first use of its FFR products in the United States | 76 | 1 |
| 6.47 Nov 06, 2015: Merit Medical Names New Chief Financial Officer | 76 | 1 |
| 6.48 Oct 28, 2015: OPSENS performs 1,000th procedure with the Optowire | 76 | 1 |
| 6.49 Oct 28, 2015: Boston Scientific Announces Results For Third Quarter 2015 | 77 | 1 |
| 6.50 Oct 27, 2015: BIOTRONIK Announces European Launch of New Generation of Galeo Coronary Guide Wires | 78 | 1 |
| 7 Appendix | 79 | 4 |
| 7.1 Methodology | 79 | 2 |
| 7.2 About GlobalData | 81 | 1 |
| 7.3 Contact Us | 81 | 1 |
| 7.4 Disclaimer | 82 | 1 |
